Antidiabetic compounds, any

32456064 2020. Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis.
32382358 ä. COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher?s Stone?

Metformin
32313883 2020. Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review)
32347974 2020. Metformin and COVID-19: A novel deal of an Old Drug

DPP4

32333972 ä. Letter to the Editor in response to the article ?COVID-19 and diabetes: Can DPP4 inhibition play a role??
32333966 2020. COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications
32333969 ä. Response to COVID -19 and Diabetes: Can DPP4 Inhibition Play a Role? ? GLP-1 Might Play One Too
32283128 ä. Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? on ace2 via adam17, nfkb via dpp4
32061923 2020. Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions
32349031 2020. Role of Dipeptidyl Peptidase 4 Inhibitors in Diabetic Patients with Coronavirus-19 Infection
32336007 2020. DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19?
32224164 2020. COVID-19 and diabetes: Can DPP4 inhibition play a role?

SGLT2
32335366 2020. Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis

PPAR
32344313 ä. Can pioglitazone be potentially useful therapeutically in treating patients with covid-19?
32365556 2020. Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-gamma as Candidates for Cytokine Storm Modulation in COVID-19 Disease